Literature DB >> 15157294

Large sphenoid wing meningiomas involving the cavernous sinus: conservative surgical strategies for better functional outcomes.

Khaled M Abdel-Aziz1, Sebastien C Froelich, Elias Dagnew, Walter Jean, John C Breneman, Mario Zuccarello, Harry R van Loveren, John M Tew.   

Abstract

OBJECTIVE: The ability to resect meningiomas that involve the medial and anterior compartments of the cavernous sinus has been refuted. In this retrospective study, we determined the efficacy of total resection of meningiomas that invade the cavernous sinus but are restricted to the lateral compartment.
METHODS: We reviewed the charts of 38 consecutive patients with sphenocavernous, clinoidocavernous, and sphenoclinoidocavernous meningiomas who underwent surgical treatment. We assessed early and late cranial nerve morbidity, extent of resection, and long-term outcome (mean, 96 mo).
RESULTS: In all patients, tumors exceeded 3 cm diameter. In 22 of 24 patients, total microscopic excision was achieved in tumors that involved only the lateral compartment of the cavernous sinus and touched or partially encased the cavernous internal carotid artery (i.e., modified Hirsch Grades 0 and 1, respectively). In 2 of 24 patients, remaining tumor infiltrated the superior orbital fissure. All 14 patients who had tumors that encased (with or without narrowing) the cavernous segment of the internal carotid artery (Hirsch Grades 2-4) underwent incomplete resection. Among 38 patients, mortality was 0%, late cranial nerve deficits remained in 6 (16%), and late Karnofsky Performance Scale scores exceeded 90 in 34 patients (90%). Four patients (10.5%) developed a recurrence or regrowth. Of 20 patients who were treated with either linear accelerator-based stereotactic radiosurgery or fractionated conformal radiotherapy, 11 had residual tumor and a moderate to high proliferative index, 4 had atypical tumors and 1 had angioblastic meningioma after total excision, 2 had regrowth, and 2 had recurrent tumors. In 18 (90%) of the 20 patients who underwent radiation, tumor size was reduced or controlled.
CONCLUSION: On the basis of this study and a review of the literature, we demonstrate that sphenocavernous, clinoidocavernous, and sphenoclinoidocavernous meningiomas of Hirsch Grades 0 and 1 can be excised from the lateral compartment of the cavernous sinus without postoperative mortality and with acceptable rates of morbidity. Residual tumor in the medial compartment (Hirsch Grades 2-4) may be treated with some form of radiation therapy or observation.

Entities:  

Mesh:

Year:  2004        PMID: 15157294     DOI: 10.1227/01.neu.0000125542.00834.6d

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  24 in total

1.  Revascularization for complex skull base tumors.

Authors:  Jorge Mura; David Rojas-Zalazar; Evandro de Oliveira
Journal:  Skull Base       Date:  2005-02

2.  Correlating hemodynamic magnetic resonance imaging with high-field intracranial vessel wall imaging in stroke.

Authors:  Weston Langdon; Manus J Donahue; Anja G van der Kolk; Swati Rane; Megan K Strother
Journal:  J Radiol Case Rep       Date:  2014-06-30

3.  Surgical Management of Tumors Involving Meckel's Cave and Cavernous Sinus: Role of an Extended Middle Fossa and Lateral Sphenoidectomy Approach.

Authors:  Daniel Q Sun; Arnold H Menezes; Matthew A Howard; Bruce J Gantz; David M Hasan; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2018-01       Impact factor: 2.311

Review 4.  Contemporary surgical outcome for skull base meningiomas.

Authors:  Chien-Min Chen; Abel Po-Hao Huang; Lu-Ting Kuo; Yong-Kwang Tu
Journal:  Neurosurg Rev       Date:  2011-05-26       Impact factor: 3.042

Review 5.  Iatrogenic carotid artery injury in neurosurgery.

Authors:  Joji Inamasu; Bernard H Guiot
Journal:  Neurosurg Rev       Date:  2005-08-10       Impact factor: 3.042

6.  Value of K i -67 Labeling Index in Predicting Recurrence of WHO Grade I Cranial Base Meningiomas.

Authors:  Jose Gabrielle Matias; Ignacio Jusue-Torres; Brendan Martin; Ankush Bajaj; Ewa Borys; Edward Melian; Kevin Barton; Douglas E Anderson; Vikram C Prabhu
Journal:  J Neurol Surg B Skull Base       Date:  2018-09-06

Review 7.  FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients.

Authors:  D Zlotnick; S N Kalkanis; A Quinones-Hinojosa; K Chung; M E Linskey; R L Jensen; F DeMonte; F G Barker; C A Racine; M S Berger; P M Black; M Cusimano; L N Sekhar; A Parsa; M Aghi; Michael W McDermott
Journal:  J Neurooncol       Date:  2010-09-18       Impact factor: 4.130

Review 8.  Management options for cavernous sinus meningiomas.

Authors:  Michael T Walsh; William T Couldwell
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  A prospective study of cavernous sinus surgery for meningiomas and resultant common ophthalmic complications (an American Ophthalmological Society thesis).

Authors:  Steven Newman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 10.  Radiotherapy and radiosurgery for benign skull base meningiomas.

Authors:  Giuseppe Minniti; Maurizio Amichetti; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2009-10-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.